Compass Therapeutics, Inc. (CMPX)
USD 1.42
(-7.19%)
USD 1.42
(-7.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -40.61 Million | -34.12 Million | -19.66 Million | -26.8 Million | -31.74 Million | -33.67 Million |
| Net Income | -42.49 Million | -39.22 Million | -82.18 Million | -29.5 Million | -34.74 Million | -38.28 Million |
| Depreciation & Amortization | 1.89 Million | 1.9 Million | 1.62 Million | 2.4 Million | 2.12 Million | 1.92 Million |
| Deferred income taxes | - | - | 50.57 Million | 837 Thousand | 109 Thousand | -261 Thousand |
| Stock-based compensation | 6.12 Million | 5.33 Million | 4.02 Million | 4.01 Million | 915 Thousand | 656 Thousand |
| Change in working capital | -2.9 Million | -1.26 Million | 6.24 Million | -3.6 Million | -257 Thousand | 2.17 Million |
| Other non-cash items | 5.96 Million | -871 Thousand | 41 Thousand | -960 Thousand | 116 Thousand | 121 Thousand |
| Investing Cash Flow | 26.96 Million | -151.2 Million | -1.77 Million | 38 Thousand | -466 Thousand | -2.02 Million |
| Investments in PPE | -30 Thousand | -212 Thousand | -1.56 Million | -106 Thousand | -466 Thousand | -2.02 Million |
| Acquisitions | - | 176 Thousand | 116 Thousand | 144 Thousand | - | - |
| Investment purchases | -155.41 Million | -200.11 Million | - | - | - | - |
| Sales/Maturities of investments | 182.41 Million | 48.95 Million | - | - | - | - |
| Other Investing Activities | 26.99 Thousand | -150.98 Thousand | -318 Thousand | 144.00 | - | - |
| Financing Cash Flow | 2.93 Million | 75.75 Million | 118.61 Million | 48.53 Million | 37.62 Thousand | 64.03 Million |
| Debt repayment | - | - | -9.37 Million | -5.62 Million | - | -14.95 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -159.00 | - | - | - | - | - |
| Common Stock Issuance | 3.09 Million | 76.23 Million | 128.26 Million | 60.48 Million | - | 49.07 Million |
| Other Financing Activities | -159 Thousand | -480 Thousand | -281 Thousand | -6.31 Million | 37.62 Thousand | 64.03 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 708 Thousand | 2.51 Million | -194 Thousand | 432 Thousand | -1.1 Million | 992 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.61 Million | -3.77 Million | 6.43 Million | -4.03 Million | 844 Thousand | 1.17 Million |
| Cash at beginning of period | 34.94 Million | 144.51 Million | 47.33 Million | 25.56 Million | 57.77 Million | 29.44 Million |
| Cash at end of period | 24.22 Million | 34.94 Million | 144.51 Million | 47.33 Million | 25.56 Million | 57.77 Million |
| Capital Expenditure | -30 Thousand | -212 Thousand | -1.56 Million | -106 Thousand | -466 Thousand | -2.02 Million |
| Effect of forex changes on cash | - | - | - | - | -37.62 Thousand | - |
| Net cash flow / Change in cash | -10.71 Million | -109.56 Million | 97.17 Million | 21.77 Million | -32.2 Million | 28.33 Million |
| Free Cash Flow | -40.64 Million | -34.33 Million | -21.23 Million | -26.9 Million | -32.2 Million | -35.69 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.78 Million | -42.49 Million | -13.41 Million | -9.96 Million | -11.27 Million | -7.83 Million |
| Depreciation & Amortization | 463 Thousand | 1.89 Million | 468 Thousand | 466 Thousand | 475 Thousand | 481 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2 Million | 6.12 Million | 1.6 Million | 1.62 Million | 1.62 Million | 1.26 Million |
| Change in working capital | -5.19 Million | -2.9 Million | -195 Thousand | 2.73 Million | 97 Thousand | -5.54 Million |
| Other non-cash items | 5.78 Million | 5.96 Million | -60 Thousand | -786 Thousand | -1.03 Million | -593 Thousand |
| Investing Cash Flow | -4.09 Million | 26.96 Million | 6.31 Million | 17.04 Million | -667 Thousand | 4.26 Million |
| Investments in PPE | - | -30 Thousand | -9000.00 | -10 Thousand | -11 Thousand | - |
| Acquisitions | - | - | 16.4 Thousand | -17.05 Thousand | 656.00 | - |
| Investment purchases | -41.87 Million | -155.41 Million | -45.07 Million | -17.37 Million | -38.04 Million | -54.91 Million |
| Sales/Maturities of investments | 37.77 Million | 182.41 Million | 51.4 Million | 34.43 Million | 37.38 Million | 59.18 Million |
| Other Investing Activities | -4099.00 | 26.99 Thousand | 6323.00 | 17.05 Thousand | -656.00 | 4269.00 |
| Financing Cash Flow | 17.43 Million | 2.93 Million | -158 Thousand | 21 Thousand | 3.03 Million | 41 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -136.00 | -159.00 | -159.00 | - | - | - |
| Common Stock Issuance | 17.56 Million | 3.09 Million | 1000.00 | 21 Thousand | 3.03 Million | 41 Thousand |
| Other Financing Activities | -136 Thousand | -159 Thousand | -159 Thousand | 21.00 | 3031.00 | 41.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -3.23 Million | 708 Thousand | 1.78 Million | 1.58 Million | -401 Thousand | -2.25 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.95 Million | -3.61 Million | -1.97 Million | 1.15 Million | 498 Thousand | 2.25 Million |
| Cash at beginning of period | 24.22 Million | 34.94 Million | 30.42 Million | 19.27 Million | 27.02 Million | 34.94 Million |
| Cash at end of period | 23.67 Million | 24.22 Million | 24.22 Million | 30.42 Million | 19.27 Million | 27.02 Million |
| Capital Expenditure | - | -30 Thousand | -9000.00 | -10 Thousand | -11 Thousand | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -554 Thousand | -10.71 Million | -6.19 Million | 11.14 Million | -7.74 Million | -7.91 Million |
| Free Cash Flow | -13.88 Million | -40.64 Million | -12.36 Million | -5.93 Million | -10.12 Million | -12.22 Million |
MEITF
AMBOAGRI
RRL
PNL
XSVT
HFEL